Kratom is a species of tree (Mitragynia speciosa) that grows in Southeast Asia and Africa. In low doses, kratom leaves act as a stimulant. In high doses, it has analgesic effects. It is not a classic psychedelic and it is unclear how much, if any, the serotonin 5-HT2a receptor is involved in the effects of kratom compounds. It is likely that the combination of effects from several different types of receptors is responsible for benefits from the compound, which include relief from symptoms of opium withdrawal, anxiety and depression. More than a dozen countries have made kratom a controlled substance, limiting the sale, use, importation, and production of kratom. Neither the UN nor the US has currently scheduled kratom, the latter is considering scheduling it as of July 2021. The FDA did ban the importation of kratom in 2014; until then it was promoted as a dietary supplement.
Highlighted Institutes
These are the institutes, from companies to universities, who are working on Kratom research.
Highlighted People
These are some of the best-known people, from researchers to entrepreneurs, working with Kratom.
Linked Research Papers & Trials
Pro & Business members will be able to see all linked papers and trials directly on this compound page.
This information is still available for you by selecting Kratom on the Papers and Trials pages respectively.
See the information directly on this page with a paid membership.